Contents
Editor’s Letter
Unmet potential of Generics and Biosimilars to reduce healthcare costs
Original Research
Pricing of oral generic cancer medicines in 25 European countries; findings and implications
Review Article
Are there biosimilar orphan drugs for Gaucher disease? An overview in Mexico
Meeting Report
2nd MENA Stakeholder Meeting on Biosimilars 2018 – Report
Abstracted Scientific Content
Escalating prices of generic drugs targeted by US anti-gouging legislation